These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18440459)

  • 21. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
    Lanuti M; Sharma A; Digumarthy SR; Wright CD; Donahue DM; Wain JC; Mathisen DJ; Shepard JA
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
    Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
    J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term.
    Ambrogi MC; Lucchi M; Dini P; Melfi F; Fontanini G; Faviana P; Fanucchi O; Mussi A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):177-83. PubMed ID: 16723242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
    Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors.
    Hiraki T; Tajiri N; Mimura H; Yasui K; Gobara H; Mukai T; Hase S; Fujiwara H; Iguchi T; Sano Y; Shimizu N; Kanazawa S
    Radiology; 2006 Oct; 241(1):275-83. PubMed ID: 16908680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does tumor type affect local control by radiofrequency ablation in the lungs?
    Hiraki T; Gobara H; Mimura H; Sano Y; Tsuda T; Iguchi T; Fujiwara H; Kishi R; Matsui Y; Kanazawa S
    Eur J Radiol; 2010 Apr; 74(1):136-41. PubMed ID: 19231125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
    Lee JM; Jin GY; Goldberg SN; Lee YC; Chung GH; Han YM; Lee SY; Kim CS
    Radiology; 2004 Jan; 230(1):125-34. PubMed ID: 14645875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
    Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
    Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months.
    Arima K; Yamakado K; Suzuki R; Matsuura H; Nakatsuka A; Takeda K; Sugimura Y
    Urology; 2007 Sep; 70(3):407-11. PubMed ID: 17905083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation of lung tumors: feasibility and safety.
    Zhu JC; Yan TD; Glenn D; Morris DL
    Ann Thorac Surg; 2009 Apr; 87(4):1023-8. PubMed ID: 19324122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
    Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
    J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.
    Clasen S; Krober SM; Kosan B; Aebert H; Fend F; Bomches A; Claussen CD; Pereira PL
    Cancer; 2008 Dec; 113(11):3121-9. PubMed ID: 18973180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
    Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary thermal ablation in patients with prior pneumonectomy.
    Sofocleous CT; May B; Petre EN; Gonen M; Thornton RH; Alago W; Rizk NP; Dupuy DE; Solomon SB
    AJR Am J Roentgenol; 2011 May; 196(5):W606-12. PubMed ID: 21512052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.